Implementation of an Allergic Rhinitis Severity Questionnaire in ENT Consultations

NCT07315945 | Recruiting

• 1 other identifier: 9692
• Study Type: observational
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Allergic rhinitis is a very common condition (affecting 1 in 5 people in Europe) and a costly one for society (direct and indirect costs). Symptoms vary depending on the time of year, and treatments are primarily symptomatic, with follow-up in ENT consultations. Scientific societies (EAACI, FDA, EMA) recommend using a universal tool (severity score) (the CSMS score, SCST in French) to monitor severity and follow-up, and to obtain consistent data that can be extrapolated to other scientific data (meta-analyses). Therefore, investigators in the ENT department use this SCST score (as well as others such as the SNOT 22 score) to assess the severity of allergic rhinitis in our patients and its progression. Tbe investigators wish to confirm the acceptability of this tool for patients, and the statistical value of its properties.

Conditions

Allergic Rhinitis

Keywords

Allergic Rhinitis; SCST score; SNOT 22 score

Outcome Measures

Primary Outcomes (1)

• Self-Assessment Clinical Symptom Score (SCST)

  1. Rating Scale Each symptom is rated by the patient according to its intensity: * 0: absent * 1: mild * 2: moderate * 3: severe 2. Calculating the Score * Add the scores for each symptom. * The total SCST score reflects the overall severity of the symptoms: * Low score → mild symptoms * High score → severe symptoms 3. Interpretation * Before treatment: establish a baseline. * After treatment: compare the scores to assess effectiveness. * A decrease in the score indicates clinical improvement.

  Up to 6 months

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult (≥18 years) having follow-up at the ENT department of Hautepierre University Hospital for allergic rhinitis

You may qualify if:

• Adult (≥18 years)
• Follow-up at the ENT department of Hautepierre University Hospital for allergic rhinitis

You may not qualify if:

• Asymptomatic individuals not requiring follow-up consultations.

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

Rhinitis, Allergic

Condition Hierarchy (Ancestors)

Rhinitis; Nose Diseases; Respiratory Tract Diseases; Respiratory Hypersensitivity; Otorhinolaryngologic Diseases; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Central Study Contacts

Léa FATH, MD

CONTACT

33 3 88 12 76 52; lea.fath@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 18, 2025
• First Posted: January 5, 2026
• Study Start: June 10, 2025
• Primary Completion: February 1, 2026
• Study Completion: February 1, 2026
• Last Updated: January 5, 2026

Record last verified: 2025-12

Locations

FR (1)